Publications by authors named "Yoshihiro Kin"

Claim this Profile
R
Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): long-term results of a multicentre, single-arm, phase 2 trial.
Kazuyuki Shimada, Motoko Yamaguchi, Yachiyo Kuwatsuka, Kosei Matsue, Keijiro Sato, Akinao Okamoto, Yoshihiro Kin, Tomohiro Kinoshita

EClinicalMedicine· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protein C deficiency with recurrent systemic thrombosis associated with compound heterozygous missense variants.
Mikio Shiba, Shuichiro Higo, Yu Morishita, Yasuhiro Ichibori, Yoshihiro Kin

Am Heart J Plus· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful Dasatinib Treatment of Epidermal Growth Factor Receptor-Mutant Lung Adenocarcinoma and -Positive Chronic Myeloid Leukemia: A Case Report.
Akihiro Tsukaguchi, Seigo Minami, Hironao Yasuoka, Yoshihiro Kin

Case Rep Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trial.
Kazuyuki Shimada, Motoko Yamaguchi, Yoshiko Atsuta, Kosei Matsue, Keijiro Sato, Yoshihiro Kin, Tomohiro Kinoshita

Lancet Oncol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis